date,title,source
Oct-18-18,Pluristem Therapeutics Selected to Present Data from Phase II IC Study at the American Heart Association Scientific Sessions,GlobeNewswire
Nov-08-18,Pluristem: Fiscal 1Q Earnings Snapshot,Associated Press
Nov-08-18,Pluristem Therapeutics Reports Fiscal 2019 First Quarter Results and Provides Corporate Update,GlobeNewswire
Nov-12-18,New Findings from Pluristems Phase II IC study: PLX-PAD Cells Significantly Improves Blood Glucose Control (HbA1c) and Reduce Chronic Inflammation,GlobeNewswire
Nov-19-18,"Report: Exploring Fundamental Drivers Behind Pluristem Therapeutics, RXi Pharmaceuticals, Saga Communications, Global Self Storage, Sequential Brands Group, and Finjan  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
